Lilly begins first clinical trial of antibody that targets SARS-CoV-2
Update: 2025-10-09
Description
Eli Lilly and Company is the first firm to begin a clinical trial of a therapeutic antibody that targets SARS-CoV-2, the novel coronavirus that causes COVID-19. AbCellera, an antibody start-up in Vancouver led the discovery of the antibody, which was isolated from one of the first people to recover ....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
